Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
Phosphodiesterase type 5 inhibitors (PDE5-Is) have recently emerged as a potential therapeutic strategy for neuroinflammatory, neurodegenerative, and memory loss diseases. Mechanistically, PDE5-Is produce an anti-inflammatory and neuroprotection effect by increasing expression of nitric oxide syntha...
Saved in:
Main Authors: | Christina Alves Peixoto (Author), Ana Karolina Santana Nunes (Author), Ana Garcia-Osta (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing Phosphodiesterase-5 inhibitors as chemoadjuvants
by: Amit K. Tiwari, et al.
Published: (2013) -
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease
by: Elham Nasiri, et al.
Published: (2020) -
Selective Vulnerability of the Locus Coeruleus Noradrenergic System and its Role in Modulation of Neuroinflammation, Cognition, and Neurodegeneration
by: Andrew K. Evans, et al.
Published: (2022) -
A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration
by: Emanuela Berrino, et al.
Published: (2023) -
Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury
by: Arthur Liesz
Published: (2015)